11 March 2022>: Clinical Research
Comparison of Pain in Male Drug Rehabilitees with and without Human Immunodeficiency Virus in Yunnan Province, China
Simin Shen 12AE , Zhangxiang Huang 1F , Xiaolina Zhang 1C , Xuejun Li 3B , Kaiyang Zhao 1BD , Kunhua Wang 24AG , Xiaomei Zhang 1AG*DOI: 10.12659/MSM.934996
Med Sci Monit 2022; 28:e934996
Table 4 PainDETECT questionnaire (PD-Q) mean scores for the drug rehabilitees with and without HIV.
Drug rehabilitees without HIV (n=44) | Drug rehabilitees with HIV (n=58) | P value | |
---|---|---|---|
70.84±1.16 | 2.3±1.93 | 0.006 | |
6.00 (13.64) | 22.00 (37.93) | 0.0061 | |
Burning pain | 2.40±0.30 | 3.04±0.18 | 0.0561 |
Stabbing pain | 2.00±0.28 | 2.76±0.16 | 0.0126 |
Tenderness | 1.37±0.17 | 2.32±0.14 | |
Lightning pain | 1.40±0.18 | 2.76±0.18 | |
Crymodynia | 1.60±0.25 | 2.43±0.16 | 0.0036 |
Numbness | 1.87±0.27 | 2.59±0.16 | 0.0193 |
Pressure allergies | 1.87±0.25 | 2.11±0.10 | 0.3003 |
Nociceptive (PD-Q score ≤12) | 34 (77.27) | 28 (28.57) | |
Mixed (PD-Q score 13–18) | 7 (15.90) | 25 (43.10) | |
Neuropathic (PD-Q score ≥19) | 3 (6.81) | 5 (8.62) | |
* values for the continuous variable comparisons were determined using the Wilcoxon rank sum test. values for the neuropathic pain category (likely/not likely) comparisons were determined using Pearson’s χ test or Fisher’s exact test if ≥25% of the expected counts were |